CIM
WST icon

Confluence Investment Management’s West Pharmaceutical WST Stock Holding History

Confluence Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-24,252
Closed -$1.46M – 244
2015
Q4 		$1.46M Sell
24,252
-220
-0.9% -$13.2K 0.05% 186
2015
Q3 		$1.32M Sell
24,472
-180
-0.7% -$10.5K 0.05% 190
2015
Q2 		$1.43M Sell
24,652
-464
-2% -$25.9K 0.05% 192
2015
Q1 		$1.51M Sell
25,116
-12,480
-33% -$665K 0.06% 188
2014
Q4 		$2M Sell
37,596
-1,329
-3% -$66.5K 0.08% 155
2014
Q3 		$1.74M Buy
38,925
+8,031
+26% +$341K 0.08% 168
2014
Q2 		$1.3M Sell
30,894
-1,553
-5% -$66.5K 0.06% 187
2014
Q1 		$1.43M Sell
32,447
-514
-2% -$24.2K 0.07% 183
2013
Q4 		$1.62M Sell
32,961
-1,993
-6% -$93.3K 0.09% 158
2013
Q3 		$1.44M Sell
34,954
-4,362
-11% -$166K 0.09% 161
2013
Q2 		$1.38M Buy
+39,316
New +$1.29M 0.1% 160

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Confluence Investment Management's WST Position: Q1 2016 in Review

Confluence Investment Management sold out of West Pharmaceutical (WST) in Q1 2016, closing a stake of 24,252 shares — an estimated $1.46M sold.

Confluence Investment Management first reported a position in WST in Q2 2013 and held it in 11 quarters. The position peaked at $2M in Q4 2014. 251 funds tracked by Wall St. Rank hold WST as of Q1 2016.

  • Confluence Investment Management reported no remaining West Pharmaceutical position as of Q1 2016 after selling out during the quarter.
  • Confluence Investment Management sold 24,252 West Pharmaceutical shares in Q1 2016, an estimated $1.46M.
  • Confluence Investment Management first reported a position in West Pharmaceutical in Q2 2013 and held it in 11 quarters.
  • Confluence Investment Management's West Pharmaceutical position peaked at $2M in Q4 2014.
  • 251 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2016.

Based on Confluence Investment Management's 13F filing for Q1 2016, filed 4 May 2016.